Menu
Advancing opportunities in treating rare diseases, giving patients an improved quality of life and better outcomes.
Through innovative research and development, quality manufacturing and years of experience, as well as listening and learning from patients, we aim to improve the lives of those suffering from rare diseases across the UK.
Quality and safety are our top priorities. Our medicines are manufactured in state-of-the-art production facilities. We track each of our drugs from creation to the finished product to ensure its pharmaceutical and therapeutic quality. These high quality standards ensure we deliver the treatments patients deserve.
The well-being of people is our focus. Our class leading products and dedicated employees, demonstrate our commitment to providing medical solutions that can benefit all those involved in the healthcare system.
We have a commitment to deliver world class treatments. A commitment to society, our employees and patients. Rigorous research, rigorous manufacturing and rigorous standards deliver innovative solutions and are supported by our CSR Annual Report, Social Projects, Patient Support and Transparency.
Our employees are our greatest asset and are committed to creating the most effective solutions for rare diseases. With a transparent, flexible and participative work place they are given the autonomy to achieve their ambitions. And by empowering them, we are empowering patients suffering from rare diseases.
We value our employees by offering them a professional environment, equal opportunities and a genuine work-life balance. We ensure our products, wherever possible, are accessible to all and offer flexible solutions to HCPs and patients.
TJ Bailey-Burnley
General Manager, UK and Ireland